A study published in ‘Diabetes Medicine’ reported that CGM is potentially beneficial for children newly diagnosed with type 1 diabetes. The researchers aimed to record the experience of parents of youth with recent-onset type 1 diabetes who initiated the use of continuous glucose monitoring (CGM) technology soon after diagnosis.

Focus groups and individual interviews were conducted with parents of youth with type 1 diabetes who started using CGM early as part of a new clinical protocol. A semi-structured interview guide was used to elicit feedback and experiences with starting CGM within 30 days of diagnosis, and the benefits and barriers they experienced when adjusting to this technology.

The average age of the participants were 16 parents(44.13 ± 8.43 years, 75% female; 56.25% non-Hispanic White) of youth (age 12.38 ± 4.15 years; 50% female; 50% non-Hispanic White; diabetes duration 10.35 ± 3.89 months) who initiated CGM 11.31 ± 7.33 days after a diabetes diagnosis. The parents expressed high levels of satisfaction with starting CGM within a month of diagnosis and described a high level of reliance on the technology to help manage their child's diabetes.

All participants recommended early CGM initiation for future families and were willing to continue using the technology to cope up the living with type 1diabetes.